Beca, J., Majeed, H., Chan, K. K., Hotte, S. J., Loblaw, A., & Hoch, J. S. (2019). Cost-effectiveness of docetaxel in high-volume hormone-sensitive metastatic prostate cancer. Canadian Urological Association Journal, 13(12), 396–403. https://doi.org/10.5489/cuaj.5889